Abstract
SARS-CoV-2 causes the complex and heterogeneous illness known as COVID-19. The disease primarily affects the respiratory system but can quickly become systemic, harming multiple organs and leading to long-lasting sequelae in some patients. Most infected individuals are asymptomatic or present mild symptoms. Antibodies, complement, and immune cells can efficiently eliminate the virus. However, 20% of individuals develop severe respiratory illness and multiple organ failure. Virus replication has been described in several organs in patients who died from COVID-19, suggesting a compromised immune response. Immunodeficiency and autoimmunity are responsible for this impairment and facilitate viral escape. Mutations in IFN signal transduction and T cell activation are responsible for the inadequate response in young individuals. Autoantibodies are accountable for secondary immunodeficiency in patients with severe infection or prolonged COVID-19. Antibodies against cytokines (interferons α, γ and ω, IL1β, IL6, IL10, IL-17, IL21), chemokines, complement, nuclear proteins and DNA, anticardiolipin, and several extracellular proteins have been reported. The type and titer of autoantibodies depend on age and gender. Organ-specific autoantibodies have been described in prolonged COVID-19. Their role in the disease is under study. Autoimmunity and immunodeficiency should be screened as risk factors for severe or prolonged COVID-19.
Funder
Multicenter Project funded by the Czech Ministry of Innovation
European Structural and Investment Operational Funds Program Research
National Institute of virology and bacteriology
The Venezuelan Foundation of Scientific Research and Technology (FONACIT) and the Ministry of Science, Venezuela
Subject
Microbiology (medical),Molecular Biology,General Medicine,Microbiology
Reference166 articles.
1. COVID-19: A Multidisciplinary Review;Chams;Front. Public Health,2020
2. Coronaviruses: An overview of their replication and pathogenesis;Fehr;Methods Mol. Biol.,2015
3. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: A review of current evidence;Rahman;Expert Rev. Clin. Pharmacol.,2021
4. Omicron variant of SARS-CoV-2: Genomic, transmissibility, and responses to current COVID-19 vaccines;Araf;J. Med. Virol.,2022
5. Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults;Kared;Nat. Commun.,2022
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献